Capecitabine For Nasopharyngeal Cancer

Clinical trial NCT00095901 · COMPLETED

Trial details

NCT number: NCT00095901
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2004-06-01
Primary completion: 2007-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.